243 related articles for article (PubMed ID: 36630669)
61. A "Dual-Source, Dual-Activation" Strategy for an NIR-II Window Theranostic Nanosystem Enabling Optimal Photothermal-Ion Combination Therapy.
Zheng Z; Duan A; Dai R; Li Y; Chen X; Qin Y; Ren S; Li R; Cheng Z; Zhang R
Small; 2022 Jul; 18(27):e2201179. PubMed ID: 35665998
[TBL] [Abstract][Full Text] [Related]
62. Highly stable organic photothermal agent based on near-infrared-II fluorophores for tumor treatment.
Xu Y; Wang S; Chen Z; Hu R; Li S; Zhao Y; Liu L; Qu J
J Nanobiotechnology; 2021 Feb; 19(1):37. PubMed ID: 33541369
[TBL] [Abstract][Full Text] [Related]
63. Full-spectrum responsive ZrO
Zhu C; Ding Z; Guo Z; Guo X; Yang A; Li Z; Jiang BP; Shen XC
Biomater Sci; 2020 Dec; 8(23):6515-6525. PubMed ID: 33141134
[TBL] [Abstract][Full Text] [Related]
64. Self-assembled organic nanomedicine enables ultrastable photo-to-heat converting theranostics in the second near-infrared biowindow.
Xiang H; Zhao L; Yu L; Chen H; Wei C; Chen Y; Zhao Y
Nat Commun; 2021 Jan; 12(1):218. PubMed ID: 33431882
[TBL] [Abstract][Full Text] [Related]
65. A Small-Molecule Based Organic Nanoparticle for Photothermal Therapy and Near-Infrared-IIb Imaging.
Lou H; Ji A; Qu C; Liu H; Jiang L; Chen H; Cheng Z
ACS Appl Mater Interfaces; 2022 Aug; 14(31):35454-35465. PubMed ID: 35900924
[TBL] [Abstract][Full Text] [Related]
66. Targeted delivery of organic small-molecule photothermal materials with engineered extracellular vesicles for imaging-guided tumor photothermal therapy.
Dong Y; Xia P; Xu X; Shen J; Ding Y; Jiang Y; Wang H; Xie X; Zhang X; Li W; Li Z; Wang J; Zhao SC
J Nanobiotechnology; 2023 Nov; 21(1):442. PubMed ID: 37993888
[TBL] [Abstract][Full Text] [Related]
67. Donor/π-Bridge Manipulation for Constructing a Stable NIR-II Aggregation-Induced Emission Luminogen with Balanced Phototheranostic Performance*.
Yan D; Xie W; Zhang J; Wang L; Wang D; Tang BZ
Angew Chem Int Ed Engl; 2021 Dec; 60(51):26769-26776. PubMed ID: 34626441
[TBL] [Abstract][Full Text] [Related]
68. Design of One-for-All Near-Infrared Aggregation-Induced Emission Nanoaggregates for Boosting Theranostic Efficacy.
Xie H; Bi Z; Yin J; Li Z; Hu L; Zhang C; Zhang J; Lam JWY; Zhang P; Kwok RTK; Li K; Tang BZ
ACS Nano; 2023 Mar; 17(5):4591-4600. PubMed ID: 36857475
[TBL] [Abstract][Full Text] [Related]
69. In Vivo Imaging-Guided Photothermal/Photoacoustic Synergistic Therapy with Bioorthogonal Metabolic Glycoengineering-Activated Tumor Targeting Nanoparticles.
Du L; Qin H; Ma T; Zhang T; Xing D
ACS Nano; 2017 Sep; 11(9):8930-8943. PubMed ID: 28892360
[TBL] [Abstract][Full Text] [Related]
70. NIR-II AIEgens with Photodynamic Effect for Advanced Theranostics.
Yin S; Song J; Liu D; Wang K; Qi J
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235186
[TBL] [Abstract][Full Text] [Related]
71. Acceptor engineering-facilitated versatile AIEgen for mitochondria-targeted multimodal imaging-guided cancer photoimmunotherapy.
Sun Z; Wen H; Zhang Z; Xu W; Bao M; Mo H; Hua X; Niu J; Song J; Kang M; Wang D; Tang BZ
Biomaterials; 2023 Oct; 301():122276. PubMed ID: 37579564
[TBL] [Abstract][Full Text] [Related]
72. π Bridge Engineering-Boosted Dual Enhancement of Type-I Photodynamic and Photothermal Performance for Mitochondria-Targeting Multimodal Phototheranostics of Tumor.
Fang L; Meng Q; Zhang Y; Su R; Xing F; Yang H; Hou Y; Ma P; Huang K; Feng S
ACS Nano; 2023 Nov; 17(21):21553-21566. PubMed ID: 37910516
[TBL] [Abstract][Full Text] [Related]
73. Nickel(II) Phototheranostics: A Case Study in Photoactivated H
Zhang R; Xu H; Yao Y; Ran G; Zhang W; Zhang J; Sessler JL; Gao S; Zhang JL
J Am Chem Soc; 2023 Oct; 145(42):23257-23274. PubMed ID: 37831944
[TBL] [Abstract][Full Text] [Related]
74. Near-Infrared II Plasmonic Phototheranostics with Glutathione Depletion for Multimodal Imaging-Guided Hypoxia-Tolerant Chemodynamic-Photocatalytic-Photothermal Cancer Therapy Triggered by a Single Laser.
Shan B; Liu H; Li L; Lu Y; Li M
Small; 2022 Jan; 18(4):e2105638. PubMed ID: 34821041
[TBL] [Abstract][Full Text] [Related]
75. Maximum Emission Peak Over 1500 nm of Organic Assembly for Blood-Brain Barrier-Crossing NIR-IIb Phototheranostics of Orthotopic Glioblastoma.
Zhao F; Zhang X; Bai F; Lei S; He G; Huang P; Lin J
Adv Mater; 2023 Jun; 35(22):e2208097. PubMed ID: 36893436
[TBL] [Abstract][Full Text] [Related]
76. A multifunctional targeted nanoprobe with high NIR-II PAI/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma.
He L; Zhang Y; Chen J; Liu G; Zhu J; Li X; Li D; Yang Y; Lee CS; Shi J; Yin C; Lai P; Wang L; Fang C
J Mater Chem B; 2021 Nov; 9(42):8779-8792. PubMed ID: 34635903
[TBL] [Abstract][Full Text] [Related]
77. Monodisperse Au-Fe
Ju Y; Zhang H; Yu J; Tong S; Tian N; Wang Z; Wang X; Su X; Chu X; Lin J; Ding Y; Li G; Sheng F; Hou Y
ACS Nano; 2017 Sep; 11(9):9239-9248. PubMed ID: 28850218
[TBL] [Abstract][Full Text] [Related]
78. Molecular Oligomerization and Donor Engineering Strategies for Achieving Superior NIR-II Fluorescence Imaging and Thermotherapy under 1064 nm Laser Irradiation.
Liu J; Xiong Y; Gao Y; Xu X; Chen K; Shen Q; Huang W; Fan Q; Wang Q
Small; 2023 Jan; 19(1):e2205640. PubMed ID: 36366913
[TBL] [Abstract][Full Text] [Related]
79. Plasmonic-doped melanin-mimic for CXCR4-targeted NIR-II photoacoustic computed tomography-guided photothermal ablation of orthotopic hepatocellular carcinoma.
Qi S; Zhang Y; Liu G; Chen J; Li X; Zhu Q; Yang Y; Wang F; Shi J; Lee CS; Zhu G; Lai P; Wang L; Fang C
Acta Biomater; 2021 Jul; 129():245-257. PubMed ID: 34082093
[TBL] [Abstract][Full Text] [Related]
80. Albumin-templated platinum (II) sulfide nanodots for size-dependent cancer theranostics.
Li M; Wang Y; Li T; Zhang J; Wang X; Luo J; You M; Yang T; Deng Y; Yang H; Ke H
Acta Biomater; 2023 Jan; 155():564-574. PubMed ID: 36328127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
